Sweden-based Elekta has won a tender offer to provide products to to China's National Health and Family Planning Commission.
NHFPC will purchase seven Leksell Gamma Knifeâ Perfexion units for about USD25 million.
Elekta says it was awarded the tender through a central procurement project organized by the NHFPC. Purchasing the Perfexion units is part of the Chinese government's continuous investment in health care.
With its large unmet need for cancer care and neurological disorders, China continues to grow and is Elekta's second largest market. Elekta has been present in China since 1982 and claims to be the the market leader with approximately 48% of the radiation therapy market share.
